Using viruses to treat bacterial infections (Video)
Written guide: Genetic Transduction: How Phages Move Bacterial Genes
Phage therapy uses viruses that infect only bacteria, and the first international guidelines now set out when doctors may use it.
Chapters
- 0:00 Full video
Video transcript
0:00 Full video
Some viruses infect only bacteria, and doctors are using those viruses to treat infections that are hard to clear. These viruses are called bacteriophages, or phages for short. In 2026, doctors got the first internationally coordinated guidelines for using phages, and the guidelines are careful about when phage therapy should and shouldn't be tried. Phages aren't a new discovery. Frederick Twort described the effect in 1915, and Felix d'Herelle described it in 1917. Clinical use still faces hurdles, and one reason is that doctors have lacked a shared set of rules. The rules matter because phages are so selective. A phage that kills the bacteria in one patient may have little or no effect on another strain of the same bacteria. So doctors choose phages for each patient. The choice starts with a lab test called a phage match. Before treatment, the lab checks whether a candidate phage kills the bacterial strain from that patient. If several pathogens are present, all of them are tested. A match alone doesn't settle the decision. The guideline asks for a team that includes the patient's physicians, clinical microbiologists and phage experts. Each case also goes into a registry. Then comes the question of who should get phages. The guideline says doctors may consider personalized therapy when established treatments have failed, aren't available or can't be used safely. It does not recommend phage therapy as a routine treatment, because controlled trials haven't yet shown how reliably it works. One large set of cases comes from Belgium. A group there reported the first 100 consecutive personalized cases, across 35 hospitals in 12 countries. Infections improved in about 77 percent of cases, and the targeted bacteria were cleared in about 61 percent. Those numbers need care, because the study had no control group. It did show that antibiotics still matter. Clearing the bacteria was 70 percent less likely when no antibiotics were given alongside the phages. Bacteria and the immune system can both push back. Bacteria became resistant to the phage in 7 of 16 tested patients. The immune system neutralized the phage in 5 of 13 patients who were screened. Researchers have also run randomized trials of phage products that weren't personalized, and those trials did not produce the expected results. For now, phage therapy remains a careful option for patients who have run out of others, and controlled trials still have to show how well it works. If this helped, please like this video and share it with a friend. It really helps us keep making these videos.